PBE News and Press, Invesco Dynamic Biotech & Genome From 04/21/21

This has been a long, long boom in the amount of money that's flowed into this sector, and I don't think I've ever seen anything like it in my own career. This has been VC money going into early-stage startups, it's been IPOs, it's been follow-on financing of already public companies....

Since U.S. Treasury bonds have fallen more than -20% in value, it looks like we might've seen a short-term bottom and an opportunity to profit in the bond market. Which sectors are performing well in the intermediate term, as well as those that are taking a breather in the short term....

One of my many favorite tools to use when analyzing the markets is a Relative Rotation Graph (or “RRG”). I’m going to focus on using RRG to explain what’s happening under the surface in the market today. You can put any benchmark in the middle, at the z...

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of thi...

Trading Invesco Dynamic Biotech & (NYSE: PBE) or any other stock for that matter requires a degree of disciple that not every investor has.  Even those that have discipline often fail to adhere to those disciplines sometimes, and this can cause problems, but hopefully the guide...

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those ...

The next move in a stock's price is often identifiable in advance.  This Invesco Dynamic Biotech & (NYSE: PBE) report attempts to do that, and in the process help investors learn how price acton can be revealing.  Trading plans for PBE make these observations actionable, b...

In our opinion, telehealth will remain the leading segment of the internet healthcare market as the market shifts away from in-person medical visits. According to Apple CEO Tim Cook, “I believe, if you zoom out into the future, and you look back, and you ask the question, ...

Our job as investors is to pay attention to the stocks we own.  Part of that involves looking at the fundamentals, but half of the disclosure comes from looking at price action. The Invesco Dynamic Biotech & (NYSE: PBE) data table below can help you with price action, and we ha...

Wall Street usually prices in events before they happen, and that is as true for Invesco Dynamic Biotech & (NYSE: PBE) as it is for any other company.  If news is anticipated, and investors want to know what to expect, a simple review of the stock's price action is one of the b...